Abstract: A subchronic oral toxicity study of dokudami extract, distilled with ethanol from the leaves of dokudami (Houttuynia cordata Thunb.), was conducted. Groups of 10 male and 10 female F344/DuCrj rats were fed dokudami extract at dietary levels of 0, 0.5, 1.5 and 5.0% for 13 weeks. There were no treatment-related adverse effects on body weight, food and water consumption, or on ophthalmology, hematology and urinalysis data. The serum BUN level was significantly increased in the 5.0% female group and remarkable elevation in absolute and relative kidney weights was also found in both sexes receiving 5.0% of dokudami extract. Furthermore, on histopathological assessment, marked mineralization at the cortico-medullary junction of the kidney was observed in the 1.5 and 5.0% female groups and the 5.0% male group. No treatment-related histopathological changes in any other organs/tissues were observed in either sex given 5.0% dokudami extract. Thus, the No-Observed-Adverse-Effect-Level (NOAEL) for dokudami extract was judged to be a dietary level of 1.5% (999 mg/kg body weight/day) for males and 0.5% (350 mg/kg body weight/day) for females under the present experimental conditions. (J Toxicol Pathol 2005; 18: 175-182) 
Introduction
Dokudami is a common plant growing wild in Asia countries. It prefers the shade and is usually found as a weed in gardens. The name "Dokudami" is derived from its quality to detoxify and its strong smell. Another name is "Juyaku" or "ten kinds of medicine" on account of its reputed therapeutic properties. Dokudami has in fact been used to cure a whole variety of illnesses as a traditional medicinal plant in Japan and China. The constituents that give it its unique smell help prevent the growth of mold and have an antibacterial effect against ringworm, and the liquid squeezed from fresh leaves can be applied to wounds, swellings and poisonous insect bites and stings. The leaves can also be applied directly to affected areas. Extracts distilled with ethanol from leaves of dokudami (Houttuynia cordata Thunb.), have also been widely used in Japan as a folk medicine with antiviral, antibacterial, antifungal, antileukaemic, immunostimulant, diuretic, anti-cancer, sedative, anti-inflammatory and antitussive effects.
However, no information regarding the toxicity of dokudami in experimental animals has hitherto been available. The objective of the present study was therefore to evaluate the toxic potential of ethanol extracts of dokudami given in the diet to both sexes of F344 rats for 13 weeks.
Materials and Methods

Dokudami extract
Dokudami extract in powder form, supplied by TOKIWA PHYTOCHEMICAL CO., LTD. (Sakura, Chiba, Japan) was prepared from leaves of Houttuynia cordata Thunb., through a process composed of extraction with 50% ethanol at a temperature of 82-84°C, concentration and freeze drying. The major component in the extract is isoquercitrin, a flavonoid. Japan). Body weight and health condition were monitored and an ophthalmologic examination was performed in the first week for quarantine and acclimation. After this period, healthy rats were selected and used for the studies at the age of 5 weeks.
The animals were housed three to a transparent polypropylene cage (26.0 × 41.2 × 19.5 cm, W × L × H, Tokiwa Kagaku Kikai Co., Ltd., Tokyo, Japan) on hardwood chip bedding (Beta chip, Northeastern Products Co., NY, USA) in an environment-controlled room. Constant conditions of temperature (22 ± 2°C), humidity (55 ± 10%), and ventilation (more than 15 times/hr) were maintained, and the room was artificially illuminated for 12 hr each day.
All experimental procedures were performed in accordance with the in-house guidelines for the Care and Use of Laboratory Animals at DIMS Institute of Medical Science, Inc.
Preliminary 2-week feeding study
From a total of 50 rats, 48 animals were allocated to four groups (6 rats of each sex / group) using a computerized stratified body weight technique and administered diet containing dokudami extract at doses of 0 (control), 0.5, 1.5 or 5.0% for 2 weeks. They were observed daily for general condition, and individual body weights were recorded on days 0, 7 and 14. Food and water consumption were measured over a 2-day period once a week. At the end of the two week treatment-period, all rats were sacrificed by exsanguination from the aorta under light anesthesia with ethyl ether, and examined macroscopically. The remaining two rats were excluded from the study.
13-Week feeding study
A total of 80 animals were allocated to four groups (10 rats of each sex/group) using the above-mentioned stratification method, and then each group was given diet containing 0, 0.5, 1.5 or 5.0% dokudami extract for 13 weeks. The selection of dietary levels was based on the results of the preliminary 2-week feeding study. The general condition of the animals was monitored daily; individual body weights were recorded weekly and food and water consumption were measured over a 2-day period before each weighing. Food efficiency values were calculated by dividing the body weight gain over one week by the food c o n s u m p t i o n v a l u e o v e r t h e s a m e p e r i o d . A n ophthalmologic examination was performed on all animals of the 5.0% and control groups before the commencement and at the end of the treatment. Details of the cornea, iris, lens and corpus were observed using an indirect electric ophthalmoscope (Inami co., Ltd., Tokyo, Japan). In representative cases, corpus pictures were taken using a fundus camera (Kowa Model RC-2, Lowa Co., Ltd., Nagoya, Japan). Midrin P (Santen Pharmaceutical Co., Ltd., Tokyo, Japan) was used as the mydriatic.
Urinalysis of samples collected over a 4-hr period (from 9:00 AM to 1:00 PM) was conducted for all animals at week 13; semiquantitative estimation (Multistix, Bayern Medical Co., Ltd., UK) of protein, glucose, ketones, billirubin, occult blood and urobilinogen was included. Specific gravity values were measured using a reflectance meter (Atago Co., Ltd., Tokyo, Japan). The levels of urinary electrolytes (sodium, potassium and chloride) were determined with a Hitachi Biochemical Automatic Analyzer 7070 (Hitachi Co., Ltd., Tokyo, Japan). Urine volumes were measured by weighing. The appearance was examined macroscopically, and urinary sediments stained by Labostain (Muto Chemicals Co., Ltd., Tokyo, Japan) were assessed microscopically. In addition, fresh urine samples were obtained from all rats, and pH values were measured using a pH meter (Hitachi-Horiba Co., Kyoto, Japan).
After the 13-week treatment period, all rats were deprived of food overnight and were then sacrificed by exsanguination from the abdominal aorta under light ether anesthesia. Blood samples collected from the aorta of each rat at the time of sacrifice were applied to hematological examinations using an automatic analyzer (Sysmex CC-180A; Toa Medical Electronics Co., Ltd., Kobe, Japan). Erythrocyte (RBC) and leukocyte (WBC) counts, the hemoglobin concentration (HGB), hematocrit value (HTC), and platelet counts were measured, and mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and mean corpuscular hemoglobin concentration (MCHC) were calculated. Differential counts of leukocytes and reticulocytes were made under a microscope with Wright and Brecher stained speciment, respectively.
Serum biochemistry and serum electrolytes were examined with a Hitachi-Biochemical Automatic Analyzer 7070 (Hitachi Co., Ltd., Tokyo, Japan). The parameters were aspa rta te aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), total bilirubin (T-BIL), blood urea nitrogen (BUN), creatine (CRE), glucose (GLU), total cholesterol (T-CHO), phospholipid (PL), triglyceride (TG), total protein (TP), albumin (ALB), the albumin/globulin ratio (A/G), calcium (CA), inorganic phosphate (IP), magnesium (MG), sodium (NA), potassium (K) and chloride (CL).
Gross observations were made at autopsy and the results recorded. At terminal sacrifice, the following organs from each rat were weighed and organ to body weight ratios determined: brain, pituitary, heart, lungs, liver, spleen, kidneys, adrenals, testes, prostate, seminal vesicles, ovaries, uterus, salivary glands, thymus and thyroids. Samples of these organs and of the lymph nodes, nasal cavity, trachea, tongue, esophagus, stomach, small intestine, large intestine, pancreas, urinary bladder, epididymis, mammary gland, vagina, spinal cord, peripheral nerve, aorta, eye, Hardelian glands, skin, bone and bone marrow, skeletal muscle, Zymbal's gland and any other tissues of abnormal appearance were fixed in 10% buffered formalin. A histopathological examination was performed on the organs and tissues listed above in the 0 and 5.0% groups rats. However, since there was tubular mineralization in the kidneys of rats in both sexes of the 5.0% group, the kidneys in the 0.5 and 1.5% groups were also subjected to additional histopathological examination. Grading {(1); slight; (2); moderate; (3); marked} was performed.
Statistical analysis
For body weight, food consumption, urinalysis, hematology, blood biochemistry and organ weight data, the significance of inter-group differences was assessed using Dunnett's multiple comparison test. For the incidence of histopathological lesions, the significance of differences observed between the 0 and 5.0% groups was evaluated with Fisher's exact probability test. The levels of significance were set an P<0.05 and 0.01.
Results
Preliminary 2-week feeding study
No noteworthy alterations related to dokudami extract treatment were observed in clinical signs, body weights or food and water consumption in any rats during the 2-week experiment. No gross pathologic findings were noted.
13-week feeding study
No clinical signs or deaths related to dokudami extract were observed throughout the 13-week period of the experiment. The body weight curves are illustrated in Fig.1 . The average body weights in dokudami extract treated groups of both sexes were not significantly different from the 0% group value at any time point. No treatment-related effects were found regarding average food and water consumption in any of the groups. Average dokudami extract intake values for male and females, were 331 and 350 mg/kg body weight/day in the 0.5% group, 999 and 1059 mg/kg body weight/day in the 1.5% group and 3330 and 3504 mg/kg body weight/day in the 5.0% group, respectively, showing a dose-dependent proportional increase (Table 1.) .
Urinalysis data are shown in Table 2 . Statistically significant decreases in pH values were noted in the 5.0 and 0.5% female groups, but without dose dependence. The urinary K + concentration was significantly increased in all male rats fed dokudami extract and in the 5.0% female group, with dose dependence. However, the other parameters examined were all within the normal ranges.
Ophthalmologic examination revealed a normal appearance of the eyes for all animals of both sexes in both the 5.0% treatment and the 0% groups at the end of the treatment period. Statistically significant changes in some parameters were noted in treated groups. However these changes were not considered to be related to dokudami extract treatment, because there was no dose dependence or the values were within the range of our background data (Table 3. ).
Serum biochemistry and serum electrolyte data are shown in Table 4 . ALT, total cholesterol and total protein in the 5.0% male group were significantly increased. These alterations were not considered to have toxicological significance, because of the very slight degree of change, and the lack of histopathologic changes in the related organ, the liver. BUN in the 5.0% female group was significantly increased. This alteration was considered to have toxicological significance, because of the kidney weight changes found in both sexes receiving 5.0% dokudami extract.
No treatment-related changes were found in treated animals at autopsy (data not shown).
The final body and relative organ weights are shown in a: One sample was not collected due to human error or was omitted from the analysis due to hemolysis. *, **: Significantly different from control group at P<0.05, 0.01, respectively. Table 5 . Relative liver weights were significantly increased in the 5.0% male group. Significant increases in the relative kidney weights were also noted in the 5.0% groups of both sexes. Relative lung weights were significantly decreased in the 0.5% male group, without dose dependence. Data for histopathological findings are summarized in Table 6 . Slight to marked mineralization in the tubules at the cortico-medullary junction of the kidneys was observed in all female rats, including the 0% group. The degree of mineralization in the 5.0 and 1.5% female groups was significantly more severe than that in the 0% group. In the males, the mineralization was slight but there was a statistically significant difference in the degree between the 5.0 and 0% groups.
No treatment-related histopathological changes in any other organs/tissues were observed in any rats given 5.0% dokudami extract.
Discussion
Dokudami has been used to cure a whole variety of illnesses, and was included in medicine books early in human history. Decanoylacetaldehyde, a major component of the essential oils in extracts from this plant, has been shown to have antibiotic activity 1,2 but it is unstable and readily decomposes in the process of distillation. Methyl nnonyl ketone, lauryl aldehyde, and capryl aldehyde contained in the herb, may have no antimicrobial activity. This plant is sufficiently popular that the Japanese Medicines Codex, prepared by the Japanese Ministry of Health, Labour and Welfare, approves it as a diuretic. Therefore, it is very important to evaluate any possible toxicological risk to man. The present study in male and female F344 rats fed diets containing 0.5, 1.5 and 5.0% of dokudami extract for 13 weeks was thus performed. No treatment-related changes regarding clinical sign, survival rates, body weights, food and water consumption, ophthalmologic findings, hematology, serum biochemistry and gross observations were noted. Treatment-related changes were limited to the kidneys. Significant increases in the absolute and relative kidney weights noted in the 5.0% male and 5.0% female groups might be related to mineralization in the kidney, along with the slight but significant increase of BUN in the 5.0% females. The 5.0% male group with a slight mineralization also had a slight increase in serum BUN, but this did not achieve significance. The urinary K + concentration was statistically increased in the treated males and the 5.0% female group, with dose-dependence. However, no alterations of other related parameters were noted. Since it is known that dokudami extract has a diuretic effect, this might explain the increase of K + in the urine, although a significant increase in urine volume was not shown in the dokudami treated groups in this study.
Minimal to mild mineralization is common in the pars recta, (initially, in the descending proximal tubule), particularly in female rats, where it occurs as early as 7 weeks of age. Renal mineralization is usually seen in rats fed a semisynthetic diet but is also seen with regular laboratory feed. The exact cause is unknown, but imbalances of calcium, phosphorus, chloride, magnesium, protein, and lipid have been implicated or shown to cause renal mineralization 3 . Although a high incidence of mineralization in renal tubules has been reported due to estrogen-type sex hormone action, no such incidence was apparent in this study 4 . Additionally, no significant nutritional imbalance was considered to have been produced. Special stains, such as Alization Red S or Von Kossa's, are recommended for the demonstration of mineralization 5 since calcium salt precipitation can occur in tissue and go undetected in routinely stained sections. In this study, we also observed positivity with Von Kossa's stain (data not shown).
In general, diuretics are known to affect the Ca 2+ and Mg 2+ balance, inducing hypocalciuria and hypomagnesemia, respectively. In this study, although urinary volume was within the normal range in the dokudami extract treated groups, mineralization of the kidney was seen in the 5.0 and 1.5% female and 5.0% male groups, and this might have been caused by the diuretic action of dokudami.
The no-observed adverse effect level (NOAEL) is generally used to calculate the acceptable daily intake (ADI) of additives and is applied as an appropriate safety factor, using 100-fold lower than the observed effect level 6 . However, food additives assessment with a comprehensive battery of toxicology tests, including a 2-year rodent bioassay for carcinogenicity 7 , is necessary. Moreover, the ADI should be based on the most sensitive animal species d i s p l a y i n g t o x i c e f f e c t s , u n l e s s m e t a b o l i c o r pharmacokinetic data are available establishing that testing in other species is more relevant to man 8 . In conclusion, based on the present findings, we judge the NOAEL for dokudami extract to be 350 mg/kg/day in female rats and 999 mg/kg/day for male rats.
The commercial demand for dokudami is about 2000 tons or more a year in Japan. The prevailing dose is 15 grams dry weight/day as a diuretic and anti-constipation health food in The Japanese Pharmacopoeia, fourteenth edition 9 . With the estimated daily dokudami extract intake by human beings, the toxicological hazard may be considered negligible. 
